Darunavir dosage and administration: Difference between revisions

Jump to navigation Jump to search
(Replaced content with "__NOTOC__ {{Darunavir}} {{CMG}}; {{AE}} {{AZ}} ==References== {{Reflist}} {{FDA}} Category:Antibiotics Category:Wikinfect")
mNo edit summary
Line 3: Line 3:
{{CMG}}; {{AE}} {{AZ}}
{{CMG}}; {{AE}} {{AZ}}


==Dosage and Administration==
<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = PREZISTA (DARUNAVIR) TABLET, FILM COATED PREZISTA (DARUNAVIR) SUSPENSION [JANSSEN PRODUCTS LP] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=814301f9-c990-46a5-b481-2879a521a16f#nlm34090-1 | publisher =  | date =  | accessdate =  }}</ref>


==References==
==References==

Revision as of 00:04, 1 January 2014

Darunavir
PREZISTA® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Dosage and Administration

[1]

References

  1. "PREZISTA (DARUNAVIR) TABLET, FILM COATED PREZISTA (DARUNAVIR) SUSPENSION [JANSSEN PRODUCTS LP]".

Adapted from the FDA Package Insert.